Beacon launches biotech incubator

Life science and real estate investment firm Beacon Capital (New York, N.Y.) launched a $30-$50 million incubator fund for life science startups in New York and New Jersey. The incubator, Beacon Pharma, will provide $30,000 to $1 million in seed funding, structured mainly as convertible debt, to biotechs that are "seeking JV and licensing partnerships to further develop their IP," as well as office, lab and manufacturing space...